Monte Rosa Therapeutics, Inc. (GLUE)

14.32 +0.06 (+0.42%) USD  |  NASDAQ  |  Sep 10, 16:00
14.33 +0.01 (+0.07%) After-Hours: 20:00
More

Monte Rosa Therapeutics Average Diluted Shares Outstanding (Annual)

Average Diluted Shares Outstanding (Annual) Chart

View Average Diluted Shares Outstanding (Annual) for GLUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Annual) Chart
Start Trial

Historical Average Diluted Shares Outstanding (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
December 31, 2023 --
December 31, 2022 --
Date Value
December 31, 2021 --
December 31, 2020 --
December 31, 2019 --

Average Diluted Shares Outstanding (Annual) Range, Past 5 Years

View Average Diluted Shares Outstanding (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Annual) Benchmarks

View Average Diluted Shares Outstanding (Annual) Benchmarks
Start Trial
Nurix Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Capricor Therapeutics, Inc. Upgrade
Cue Biopharma, Inc. Upgrade